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Abstract 
Background: Medication therapy management (MTM) has been shown to resolve medication-related problems and decrease health 
care expenses. Public and private health insurers, providers, and other stakeholders are looking for ways to involve patients in the 
MTM process. One option is to engage patients through the use of a medication risk questionnaire. Objective: To investigate older 
adults’ perceptions of completing a medication risk questionnaire and receiving a rating of their risk for medication-related problems.  
Methods: Four, 75 to 90 minute focus groups were conducted using a semi-structured interview guide and copies of a medication risk 
questionnaire to collect qualitative data from 36 community dwelling older adults in Iowa, USA. Sessions were audio-recorded, 
transcribed, and analyzed thematically using an iterative process.  Results: The thematic analysis yielded a general theme of 
comprehensive medication reviews, and two themes on the medication risk questionnaire: “process and items” and “risk category  
reactions.”  Overall, participants were unfamiliar with pharmacist services beyond counseling. They were open to the questionnaire, 
but suggested it would be more useful as a topic for discussion with a provider than to screen patients. Despite their medication risk 
rating, most did not express interest in seeking a comprehensive medication review based on the result of the questionnaire as they 
considered themselves at low risk for problems. Conclusions:  Using a medication risk questionnaire as a topic for discussion could 
provide health insurance plans or providers an opportunity to increase beneficiary familiarity with MTM. These beneficiary 
perspectives may be useful to health plan administrators and MTM providers as they pursue new ways to involve patients in the 
medication management process. 
 
 
Introduction 
Medication-related problems result in significant morbidity 
and expense.
1-5
 Research shows medication therapy 
management (MTM) and other pharmacist-provided 
interactive services are effective for improving outcomes 
related to these problems.
2,6-9
 The U.S. Centers for Medicare 
and Medicaid Services (CMS) mandate Medicare Part D plans  
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offer MTM to targeted beneficiaries using three claims-based 
eligibility criteria: number of medications, number of chronic 
conditions, and medication expenditures.
10
  
 
While utilizing claims to determine eligibility is efficient, 
patients who could benefit from the service may be omitted 
given the established criteria. Furthermore, it circumvents 
patients and their ability to provide information useful for 
MTM targeting. Persons can report factors besides the three 
mandatory eligibility criteria that are associated with 
medication-related problems. For instance, use of over-the-
counter or herbal medications can lead to potential drug 
interactions; or non-adherence can lead to sub-optimal 
outcomes.
11-14
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In addition, engaging patients in MTM targeting may increase 
their awareness of MTM services and expose them to the 
potential value of MTM. This especially is relevant for 
interactive, person-to-person consultations such as 
comprehensive medication reviews (CMRs). Part D plans are 
required to make annual CMRs available to targeted 
beneficiaries
15
, but beneficiary participation is optional and 
often must be sought out. Utilization of CMRs has been 
relatively low
16,17
 and authors suggest this may be due to 
persons not perceiving added value in these pharmacist 
consultations, not viewing CMR provision as a role for 
pharmacists, or simply lacking awareness of this Part D 
benefit.
18-21 
 
Pursuing alternative strategies for identifying persons who 
could benefit from MTM services could help increase 
participation.
16 
One MTM service administrator has 
attempted to engage beneficiaries in the MTM targeting 
process through an online medication risk questionnaire. The 
questionnaire (a similar version is included in Appendix A), 
asks patients to self-report the presence of risk factors shown 
in the literature to be associated with medication-related 
problems.
11-14,23-41
 These include multiple disease states, 
increasing age, living alone, higher number of medications, 
use of OTCs, use of multiple prescribers and pharmacies, 
recent hospitalization, and unintentional and intentional non-
adherence. Summing the number of “yes” answers on the 
questionnaire provides the beneficiary with a low, medium, 
or high risk level for medication-related problems, and a 
corresponding recommendation of their need for MTM 
services.
 
 
This questionnaire follows a research lineage initiated by 
Kocheller et al.
42
 In their study, six prognostic indicators were 
developed by an expert panel to screen ambulatory patients 
and identify those that may benefit from pharmacist 
monitoring. Later, Levy added four questions to create a 10-
item, self-administered questionnaire designed to identify 
patients at risk for having medication-related problems.
43
 
Here, more  “yes” answers on the questionnaire was 
associated with more medication-related problems, although 
the association with five of the items was not statistically 
significant. Most recently, Langford et al. implemented a self-
administered questionnaire using the five significant items 
from Levy’s study in a family health center.
44
 Patients were 
divided into two groups. In one group patients were 
automatically referred to see a pharmacist if they self-
reported “yes” to at least three of the questionnaire items. 
Patients in the other group were referred using traditional 
means (e.g. physician referral). This study showed automatic 
referral increased the proportion of patients meeting with a 
pharmacist. 
These studies begin to support the ability of a medication risk 
questionnaire to identify patients who may benefit from 
MTM and increase MTM utilization. However, little about 
such questionnaires has been explored from the patient’s 
perspective - particularly among older adults eligible for MTM 
through Medicare Part D. While several published studies 
have reported older adult perceptions of MTM services such 
as CMRs since the advent of Medicare Part D,
18-21,45
 research 
is needed to investigate means to increase patient demand, 
improve MTM targeting, and increase patient engagement in 
these processes.  
 
Objectives 
The objectives of this study were to investigate older adult 
perspectives on completing a medication risk questionnaire 
and on receiving a rating of their risk for medication-related 
problems in the context of being targeted for a 
comprehensive medication review. 
 
Methods 
This study used focus groups as the method of qualitative 
data collection due to the flexibility and efficiency in 
capturing responses to questions posed by the moderator in 
addition to discussions between participants.
46-48
 
 
Four 75-90 minute focus groups were conducted in English at 
a public library in a private meeting space during the summer 
of 2010. Participants also completed an exit demographics 
survey which included age, gender, ethnicity, Medicare Part D 
prescription coverage, health status, education, and if in the 
past year they had talked to their doctor or pharmacist about 
a medication side effect or other problem. This study was 
approved by the Institutional Review Board at the University 
of Iowa.  
 
Participants were recruited using a registry of older adults 
maintained by the University of Iowa College of Public Health 
for research on aging. One-hundred registry members 
randomly were selected from a total of 450 persons 65 years 
or older, having at least one medical condition, and living in 
the local area. Letters were mailed by the registry to inform 
these persons of the study details. Thirty-six agreed to 
participate and attended one of the four sessions. A $20 gift 
card was offered to each attendee for participating.  
 
The questions asked in the focus groups (Appendix B) were 
developed by the research team. The questions were 
designed to be open-ended and neutrally worded. A pretest 
was conducted to evaluate and improve the flow of the 
interview guide. Additionally, after each focus group, minor 
modifications were made to the interview guide to improve 
clarity or direction.  
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Focus groups primarily were moderated by MW with 
occasional group prompts by WD. Each  session began with 
approximately seven questions about CMRs to provide 
context for the questionnaire followed by  10-15 questions 
relating to the questionnaire and related processes. CMRs 
were described to participants as a 20-30 minute, private, 
scheduled, sit-down service, often provided by a pharmacist. 
During a CMR a pharmacist and patient would discuss the 
patient’s medications and the pharmacist would identify 
problems or potential problems and work with the patient 
and the physician to make any changes. The CMR questions 
were intended to get participants thinking and talking about 
pharmacist-provided services. 
 
Focus group participants had the opportunity to complete the 
medication risk questionnaire (Appendix A) during the session 
(used with permission from the MTM plan administrator). 
Questionnaires were scored using the weights suggested by 
the MTM plan administrator and risk scores were provided to 
the participants. Most items were valued at 1-point except 
items 11-15 which were assigned 2-points. A score of 0-10 
placed a respondent in the low category, 11-20 in the 
moderate category, and greater than 20 in the high category. 
To make participants more comfortable with sharing their 
thoughts about the questionnaire they were told either 
actual or made-up responses to the items could be used and 
that their questionnaire   responses would not be analyzed.  
 
Focus groups were audio-recorded, transcribed verbatim by 
MW, EC, and MM, and entered into Microsoft Excel. 
Transcripts and written notes from the focus groups were 
analyzed by MW, EC, and MM using an inductive approach of 
thematic analysis.
46
 First, the coders familiarized themselves 
with the transcripts and met to generate initial codes. During 
this discussion the research team decided to separate quotes 
into two groups – those pertaining to CMRs and those 
pertaining to the medication-risk questionnaire. For the first 
transcript, each coder independently assigned codes to each 
statement to describe the nature of the statement. After 
individually coding this transcript, the coders met to discuss 
each statement and reach a consensus on the codes applied 
to each statement. This process resulted in a final list of codes 
which were used to code the remaining three transcripts. 
Each researcher coded one of the three remaining transcripts 
and the codes were reviewed by the other coders. 
Discrepancies were resolved using a consensus method. The 
codes were then collated into potential themes and reviewed 
by the research team. Researchers reviewed the codes, 
themes, and field notes to produce a description of the focus 
group findings. The description used representative quotes 
and summaries to highlight frequently voiced sentiments, 
unique or compelling ideas, and areas where participants 
appeared to have mixed or opposing viewpoints, in order to 
systematically portray the range of content of the four focus 
groups. 
 
Our initial anticipated findings were that participants would 
have heightened awareness of their risk for medication-
related problems after completing the questionnaire. This 
would result in an increased perception of the value for 
meeting with a pharmacist in an MTM visit and an increased 
desire to participate in a MTM program through their 
prescription drug benefit. 
 
Each member of the research team was a pharmacist or 
student pharmacist at the time of the study. Although 
participants were told pharmacists were only one possible 
provider of MTM and CMRs, the researchers tended to refer 
to pharmacists as the default provider to add focus to the 
discussion. BN had a very limited role in the study analysis 
due to his potential stake in the research findings. 
 
Results 
All but one participant completed a demographic 
questionnaire at the end of their focus group. The mean age 
for these participants was 74, 17 (49%) were female, all were 
Caucasian, 25 (71%) had completed a college degree and 23 
(66%) reported having Medicare Part D. The average number 
of prescription medications reported for this group was 3.4 
(range 0 to 11), all reported their health as being good, very 
good, or excellent, and 16 (46%) reported having discussed a 
side effect, unwanted reaction, or other medication-related 
problem with their physician.  
Three main themes emerged from the focus groups (Table 1):  
comprehensive medication reviews, medication risk 
questionnaire process and items, and medication risk 
questionnaire risk category reactions.  
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Table 1: Main themes and findings 
 
COMPREHENSIVE MEDICATION REVIEWS 
1. Questioned the need for CMRs 
2. Preference for usual pharmacist, face-to-face 
MEDICATION RISK QUESTIONNAIRE PROCESS AND ITEMS 
1. Questioned the usefulness of the 
questionnaire to screen patients 
2. The questionnaire should be the start of a 
discussion. 
3. Preferred mail over telephone for 
questionnaire administration 
4. Add poor eyesight and avoid the term 
“confused” for items 
MEDICATION RISK QUESTIONNAIRE RISK CATEGORY REACTION 
1. Did not believe they should be in their given 
category 
2. Wanted more information and to discuss 
decreasing risk factors 
3. Aversion to risk language 
4. Medication risk was an abstract concept 
5. Low urgency for getting CMR given their risk 
category 
6. More likely to act following a personal 
discussion 
 
Comprehensive Medication Reviews 
MIXED VIEWS ON THE NEED FOR CMRS 
Most participants were not familiar with CMRs as a Part D 
benefit or with pharmacists providing these types of services. 
Participants had mixed views on who might benefit and if a 
special service was needed in addition to counseling. In 
general, participants tended to prefer local interactions with 
providers with whom they have an existing relationship. 
 
After being provided with a definition of a CMR, participants 
had mixed views on who would be a good candidate. Some 
believed everyone could benefit from this service whereas 
others thought persons taking numerous medications, those 
who have trouble managing their medications, or those who 
experience unwanted side effects of their medications would 
derive benefit. 
 
“Anyone who is taking more than four medications 
certainly should have them reviewed. Whether those of 
us who have less have to have it done every year is 
another question.” 
 
An alternative view was CMRs would not be beneficial 
because the counseling they receive from their pharmacist is 
adequate.  
 
“This would be a waste of time for me personally. 
Whenever I have a new medication the pharmacist talks 
to me. I don’t have to make an appointment. He doesn’t 
give me the medication until he’s sure I understand what 
it’s for.” 
 
Several were concerned about pharmacists proposing 
changes to their medication regimens and wanted to make 
sure the doctor would be the person making changes.  
 
“I kind of like the doctor deciding what medications that I 
would want to be on.” 
 
PREFERENCE FOR USUAL PHARMACIST, FACE-TO-FACE 
When asked if they would be willing to see a pharmacist 
other than their usual one for a CMR, there was strong 
preference among participants to see their own pharmacist 
with whom they have a relationship.  
 
“They don’t know you. They don’t know what you’re 
taking, why you’re taking it, where your pharmacist does. 
It’s kind of like your insurance, getting the things through 
the insurance and then they decide you don’t need this. 
Well you know they live out of their offices in Timbuktu 
and they’ve never met you and don’t know anything 
about you. You just feel like they’ve never met you and 
don’t know anything about you.”  
 
Participants also said they would be much more willing to 
participate if the CMR was face-to-face rather than over the 
telephone.  
 
“I would be a lot more comfortable (Many voices: Yeah, I 
would too). Face-to-face is much better, and if it’s 
someone you trust like your pharmacist, then it would be 
really good.” 
 
Overall, participants seemed most interested in pharmacists 
addressing medication interactions, use of herbal and over-
the-counter medications, and monitoring medication side 
effects during a CMR.  
 
Medication Risk Questionnaire Process and Items 
QUESTIONED THE USEFULNESS OF THE QUESTIONNAIRE TO SCREEN 
PATIENTS 
Participants had mixed views on the utility of using this 
questionnaire to identify patients who could benefit from a 
CMR. Some expressed pharmacists should simply be able to 
offer the service to patients who could benefit, making the 
questionnaire unnecessary. 
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“Why can’t you just talk to your pharmacist and say, 
these are the drugs… I’ve never done it, but I don’t think 
they’d turn me away if I said I’m taking all these drugs, 
can you tell me a little about them?” 
 
Several perceived the questionnaire as a potential 
information source for providers rather than a screening tool 
for the insurer.  
 
“Filling out a form is okay, but if you know it’s going to 
your doctor or pharmacist… if you’re doing it for a 
purpose.” 
 
THE QUESTIONNAIRE SHOULD BE THE START OF A DISCUSSION 
Participants had mixed views on how the questionnaire 
should be administered. Participants agreed that ideally the 
questionnaire would be administered in the patient’s usual 
pharmacy or at their physician’s office. This would allow for 
immediate feedback and the questionnaire could serve as a 
tool for discussion and education.  
 
“I think it’s real good to have someone look at your 
medications and tell you what they think of, or any red-
flags that go up. But rather than being called, if someone 
at the drug store would just ask when I am there if I 
would like this service, I think that would be better.” 
 
PREFERRED MAIL OVER TELEPHONE FOR QUESTIONNAIRE 
ADMINISTRATION 
Most were wary of being called at home to complete the 
questionnaire. First, many reported not answering calls from 
an unknown number. Second, several wanted more time to 
think about their answers than telephone would allow and 
were concerned about the fidelity of how their answers 
would be recorded.  
 
“I prefer mail because then you get to think about it a 
little longer.” 
 
“I would rather fill it out myself than to give it to 
somebody else and trust that they wrote the same thing 
down that I said, because that’s a source of error.” 
 
ADD POOR EYESIGHT AND AVOID THE TERM “CONFUSED” FOR ITEMS 
Participants had several recommendations for additions, 
modifications, and clarifications to the questionnaire items 
(Appendix 1). Notably, several participants suggested “poor 
eyesight” would be important to add as a condition as 
patients with low vision might be at risk for taking the wrong 
medication doses (e.g. warfarin). Participants across focus 
groups also reacted strongly to question 11 which asked if 
they ever get confused about having taken a dose of a 
medication. The general consensus was “forget” would be 
more appropriate than “confused.”  
 
“I don’t get confused, I just get busy and I forget.” 
 
Medication Risk Questionnaire Risk Category Reactions 
DID NOT BELIEVE THEY SHOULD BE IN THEIR GIVEN CATEGORY 
Many were surprised by the risk category they received after 
filling out the questionnaire and questioned its validity. Some 
questionnaire items were not seen as risk factors by some 
members of the group. 
 
“I was a little surprised… though I have multiple doctors 
and multiple medications, I really felt confident in the 
doctors who I have… I didn’t know what the categories 
are, but I expected I’d be in low.” 
 
WANTED MORE INFORMATION AND TO DISCUSS DECREASING RISK 
FACTORS 
Some participants desired to learn more about the responses 
which led them to be in their risk category.  
 
“I need to see what I’m doing wrong.” 
“If a person tells me I am a bad golfer, that doesn’t tell 
me much. But if they tell me my swing is bad, my stance 
am I using the wrong club…” 
 
Participants were particularly interested in learning about 
modifiable risk factors. Some suggested the questionnaire 
administration could be “more of an educational process” 
where the items could lead to a discussion with a doctor or 
other health care professionals. 
 
“I think particularly for the questions here, these are the 
ones that could really lead to a discussion with a doctor, 
or whoever would want to know if you were on or would 
take vitamins, herbals, medicines, things like that… I 
think that’s crucial and an important part of this whole 
discussion.” 
 
AVERSION TO RISK LANGUAGE 
Furthermore, some of the participants expressed discomfort 
with the terms “risk” and “risk factors.” 
 
“*Risk factor+ in my mind is a red flag. And rather than 
have a red flag come up, I would rather that it be a white 
flag, a nice neutral word like ‘predictor’ is not I have it, 
but it might predict something.” 
 
MEDICATION RISK WAS AN ABSTRACT CONCEPT 
Despite completing the 15-item questionnaire minutes earlier 
and being told the questionnaire consisted of questions 
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shown to be related to medication problems, many were 
unable to connect how their responses contributed to their 
risk category. 
 
“What are the risk factors?  I’m interested in that. 
 Everyone talks about risk factors, low number, multiple, 
high...” 
 
The concept of an overall risk index may have been too 
abstract for many participants to comprehend and comment 
on in depth. One suggestion from the respondents was to 
eliminate the ‘low, moderate, high’ descriptions. 
 
“Maybe you don’t need this score, maybe when they get 
something they just get one line that says based on your 
questionnaire we think you could learn a lot from a 
conference. Or say from your questionnaire it doesn’t 
appear that the conference is going to be much benefit 
to you. Instead of saying something like low, moderate or 
high. Just give them one response, based on your 
questionnaire it looks like…” 
 
Some suggested the rating and recommendation part of the 
questionnaire should focus more on the benefit of MTM for 
the person completing the questionnaire. 
 
“I think phrasing it in terms of why. You need to sell this 
person on it. It’s good for you – not just you are a good 
candidate… we get that from Publishers 
Clearinghouse
©
.”  
 
LOW URGENCY FOR GETTING A CMR AFTER GETTING THEIR RATING 
When asked who they would talk to after receiving their risk 
category, the participants mentioned their physicians and 
pharmacists. However, trust in a provider also appeared for 
some to lead to inaction. 
 
“I guess I might ask the pharmacist… They’ve always 
been very helpful and informative, so I just have a feeling 
of trust that I probably wouldn’t do anything… or at least 
would just mention it and see what the response would 
be.” 
 
Overall there was little urgency among the groups. 
 
“I would probably simply wait until the next time I was at 
the pharmacy and talk to them then and set something 
up. I don’t think I would make any special effort. I 
suppose if I was in high I would make a special effort. I 
would follow up but not make a big deal out of it.” 
 
 
MORE LIKELY TO ACT FOLLOWING A PERSONAL DISCUSSION 
Some participants doubted they would act on a 
recommendation made by a questionnaire from someone at 
the insurance company, whereas they might be more inclined 
to act on a recommendation from one of their providers. 
 
“ The pharmacist ought to be able to say you’ve got 
enough medications here that you’d benefit from it… My 
pharmacist said that? I’ll do it. If my doctor said that… 
But other than that, this isn’t gonna send me to that 
program now.” 
 
Discussion 
This study investigates the use of a medication risk 
questionnaire in the MTM targeting process. Previous 
research suggests a self-administered medication risk 
questionnaire could be useful for screening patients at risk 
for medication-related problems who may benefit from 
meeting with a pharmacist.
44
 Findings from the present study 
suggest an additional role for a self-reported questionnaire 
could be to engage patients in the MTM targeting process.  
 
COMPREHENSIVE MEDICATION REVIEWS 
Each focus group began with an introductory discussion of 
comprehensive medication reviews (CMRs) to provide 
context for the questionnaire. In general, participant 
perspectives on CMRs corroborate previous authors’ findings 
that patients are relatively uninformed about MTM services 
such as CMRs and their provision by pharmacists.
20,49.50
 In 
addition, they did not perceive differences between the 
prescription counseling they receive at their local pharmacy 
and the CMR service described by the focus group 
moderator.
 
The authors of this study join others in identifying 
a need for payers and providers to bolster MTM marketing to 
increase public awareness of MTM services such as CMRs.
18-
20,49 
Engaging beneficiaries in MTM targeting may provide an 
additional opportunity to inform them about the purposes, 
benefits, and processes of MTM; especially in relation to 
patient-specific factors that influence the extent to which a 
patient may benefit from MTM. This study suggests such 
engagement could occur following administration of a 
medication risk questionnaire at the patient’s usual 
pharmacy.  
 
MEDICATION RISK QUESTIONNAIRE PROCESS 
Several issues emerged from the thematic analysis related to 
the medication risk questionnaire process. First, focus group 
participants did not find connecting their self-reported risk 
factors, their rating, and their recommendation to be 
intuitive. Participants may have needed more information 
throughout the process to understand the connection 
between the risk factors and medication-related problems. 
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This finding goes against our original notion that the 
questionnaire alone would help patients see that MTM could 
be beneficial based on their personal situation. Learning 
about risk factors could help beneficiaries make more 
informed decisions about how actively they want to 
participate in their plan’s MTM program. For example, a 
pharmacist could discuss the risks of taking non-prescription 
medications in the presence of prescription medications and 
how she could help check for interactions. Providing details 
about risk factors and engaging in a discussion with a health 
professional about MTM could be desirable for patients who 
display a desire for more information. 
 
RISK PERCEPTION AND THE PHARMACIST 
Participants seemed to recognize the potential for MTM to 
benefit others; however, they perceived low personal risk. 
Part of this sentiment could be explained the general good 
health of the participants. This sentiment also is supported by 
the participants who expressed high levels of confidence in 
the care provided by their physicians and pharmacists and 
hence, did not perceive a need to add MTM services. A 
medication risk questionnaire could be useful in helping 
patients identify a need for a CMR even though they may feel 
healthy. Pharmacists may consider using the technique of 
personal selling (e.g. asking probing questions and presenting 
benefits)  and the strategy of motivational interviewing (e.g. 
expressing empathy and developing discrepancy) in addition 
to the questionnaire to increase awareness of MTM and 
demonstrate how it may be of value to the patient.
51,52
  
 
Participants were averse to the focus of the questionnaire 
feedback centering on risk factors. Instead, some suggested 
focusing on the benefits of MTM services rather than using an 
overall risk rating. This finding partially may be due to the 
social undesirability of having risk factors as evident by 
several participants regarding the questionnaire results as 
inaccurate. Nevertheless, focusing on benefits could be 
important since participants initially had a difficult time 
envisioning how MTM services were different than the 
counseling already received at the point of dispensing. 
Informing patients about specific benefits may increase their 
interest in pursuing MTM services. 
 
PHARMACIST-PATIENT RELATIONSHIP 
Consistent with previous research, a few participants were 
wary of pharmacists instead of physicians making 
recommendations for medication regimen changes.
21
 While 
there was uncertainty of pharmacists in this advanced role, 
participants expressed significant satisfaction and trust with 
their pharmacist in more traditional roles. Pharmacists hoping 
to expand services could capitalize on the relationships and 
trust with their patients and personally offer MTM services to 
eligible beneficiaries.
51
 
 
Participants favored face-to-face interactions for MTM 
services and questionnaire administration. This is consistent 
with the positions of several pharmacy professional 
organizations.
16
 Our participants mostly viewed telephone 
MTM services as acceptable only when other alternatives 
were not available, for example, participants utilizing mail-
order pharmacy. The focus group participants, however, may 
not be representative of all patients, as the characteristics 
making them comfortable enough to sign up for focus groups 
may be similar to those driving their desire for face-to-face 
interactions with health care providers. Therefore, further 
investigation of MTM and CMR delivery is warranted, 
especially as others have reported high satisfaction with 
telephone MTM services.
45 
 
Overall, participants in these focus groups were more 
interested in the questionnaire as a topic for discussion with 
a health care provider than as a screening or eligibility tool. 
Thus, it appears that completing such a questionnaire and 
discussing the results with their physician or pharmacist 
would support engaging patients in the MTM targeting 
process.  
 
Limitations 
The older adults in these focus groups were well-educated, in 
good health, and lived in one Midwestern city in the USA. 
Future studies should target persons with poorer health, 
lower income and education, and minority status as these 
groups are likely to have different perspectives, especially 
considering they likely have a greater need for medication 
management. Also, participants were aware the investigators 
were from a college of pharmacy. While this may have 
altered expressions from some participants, most appeared 
forthcoming with positive and negative opinions of 
community pharmacists. 
 
Conclusion 
This study describes qualitative findings from four focus 
groups of older adults regarding a medication risk 
questionnaire. Most participants expressed little urgency for 
pursuing a CMR after receiving their questionnaire results. 
This may be due to participant aversion to the risk-centered 
focus of the questionnaire and to their perception of low 
personal risk for medication-related problems. Participants 
were, however, interested in discussing the questionnaire 
with their physician or pharmacist. This may be an 
opportunity to discuss the potential benefits of MTM with 
patients who are unfamiliar with the service. The approach of 
engaging beneficiaries in MTM services through a medication 
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risk questionnaire warrants further investigation. This study 
can be useful to MTM plan administrators and MTM 
providers as they pursue new ways to engage patients in 
MTM services. 
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Appendix A: Medication Risk Assessment Questionnaire 
 
Medication Risk Assessment Form 
This is a voluntary questionnaire regarding medications. You may use your own information, make up information, or just simply 
read over the assessment form. After answering these questions we will provide you with a score that reflects your risk of 
medication-related complications. Based on your evaluation of this assessment form or your medication risk score we would like to 
hear your responses to receiving such risk information. Please place a check mark next to the information that applies to you. Feel 
free to ask any questions if you are not sure exactly what a question is asking. 
 
1. What medical condition(s) have you been diagnosed or treated for?  
___ Acid Reflux    ___ Depression  ___ Osteoporosis 
___ Arthritis    ___ Diabetes  ___ Ulcer 
___ Asthma/COPD   ___ Heart Failure ___ Chronic Pain 
___ Hypertension (High Blood Pressure) ___ Migraine  ___ Prostate Condition 
___ Dyslipidemia (High Cholesterol) ___ Transplant  ___ Thyroid Condition 
2. How many prescription medications do you currently take on a regular basis? 
___ None  ___ 1-3  ___ 4+ 
3. Are you 65 years of age or older? 
___ Yes  ___ No 
4. Do you live alone? 
___ Yes  ___ No 
5. Do you have more than one person prescribe medications for you? 
___ Yes  ___ No 
6. Do you sometimes get prescriptions filled at more than one pharmacy, including mail-order? 
___ Yes  ___ No 
7. Do you take any non-prescription or over-the-counter medications regularly? 
___ Yes  ___ No 
8. Do you take any vitamins, herbals, or supplements regularly? 
___ Yes  ___ No 
9. Have you ever experienced a reaction to a medication that caused you to visit the ER or hospital? 
___ Yes  ___ No 
10. Have you been admitted to the hospital in the past 30 days? 
___ Yes  ___ No 
11. Do you sometimes get confused whether or not you have taken a dose of your medication? 
___ Yes  ___ No 
12. Do you ever take any medications without knowing what they are for? 
___ Yes  ___ No 
13. Do you sometimes experience unwanted side effects from any of your medications? 
___ Yes  ___ No 
14. Do you sometimes feel that your medications are not working? 
___ Yes  ___ No 
15. Do you sometimes have problems affording your medications? 
___ Yes  ___ No 
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Medication Risk Assessment Rating 
 
Based on your responses to this assessment form, your medication risk index is:   
 
_____ Low  You have a low number of risk factors that are associated with medication-related complications. You may 
wish to consider Medication Therapy Management (MTM) services if you experience health changes or would 
like preventative assistance. 
 
 _____ Moderate You have multiple risk factors associated with experiencing medication-related complications. You are a good 
candidate for Medication Therapy Management (MTM) services.       
 
_____ High You have a high number of risk factors associated with experiencing medication-related complications. You 
are an excellent candidate for Medication Therapy Management (MTM) services.       
 
 
 
 
Appendix B: Questions from Focus Group Interview Guides 
 
 Introduction, CMR Discussion 
o What do you think of getting a Comprehensive Medication Review? 
o Do you think you need a CMR if you get counseling when you pick up your prescriptions? 
o What do you think puts patients at risk for having medication problems? 
o What if your local pharmacist didn’t offer the Comprehensive Medication Reviews, would you be willing to go to a 
pharmacist at a different pharmacy 
o What do you think about having a CMR over the telephone? 
 Questionnaire-related Questions 
o Are there any questions you didn’t like or thought were unrelated to having medication problems?  
o Are there any questions you think are associated with medication problems we didn’t ask? 
o Would you fill out a questionnaire like this if your Medicare Part D plan sent it to you in the mail? What if you had to 
score it at home? 
 What if they called to have it filled out over the phone? 
 What if the questionnaire was on a website? 
 What if your pharmacist asked you to fill it out at the pharmacy? 
o What concerns would you have and how could these concerns be addressed? 
o What do you think about the wording for the categories? 
o Was anyone surprised or concerned by their rating? And if so, why? 
 What would you do? Who would you talk to? 
o Would getting your rating make you want to sign up for a medication therapy management service?  
